Delivery Order SPE2DB22D3016-SPE2DB24FBEA0
Award Date
8/14/24
Potential Completion Date
8/15/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Emgality 300 mg (100 mg x 3 syringes) medication. The contract has a ceiling value of $1,495.32 and a performance period through March 13, 2024. This award is a delivery order under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Emgality 300 mg (100 mg x 3 syringes) medical supplies. The contract has a ceiling value of $9,219.39 and a completion date of January 18, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,932.23, is for the delivery of Emgality 120 mg/ml injection medication. The contract has a firm fixed price pricing type and a completion date of April 10, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Emgality 300 mg (100 mg x 3 syringes) medication. The contract has a ceiling value of $3,186.38 and a period of performance through October 22, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,593.50 Firm Fixed Price Delivery Order covers the supply of Emgality 120 mg/mL injectable medication, with a period of performance through December 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,291.13, is for the supply of the prescription medication Emgality 120 mg/ml. The contract has an ultimate completion date of April 21, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Emgality 120 mg/ml injectable medication, with a ceiling value of $1,671.20 and a period of performance through November 4, 2024. The contract is a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,416.16 firm-fixed-price delivery order is for the supply of Emgality 120 mg/ml pen injector medication, with a period of performance through July 12, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Emgality 120 mg/ml injectable medication. The $2,563.62 contract has a completion date of March 28, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through November 2026, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,558.13 firm fixed-price delivery order is for the pharmaceutical product Emgality 120mg/ml in a quantity of 1 single-use syringe. The contract has an ultimate completion date of August 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) vehicle with the DLA Troop Support Medical, valued at up to...